PFG
IDXX icon

PAX Financial Group’s Idexx Laboratories IDXX Stock Holding History

PAX Financial Group’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,255
Closed -$549K – 229
2023
Q3 		$549K Buy
+1,255
New +$626K 0.13% 149
2022
Q1 		– Sell
-488
Closed -$321K – 208
2021
Q4 		$321K Buy
+488
New +$306K 0.07% 165

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PAX Financial Group's IDXX Position: Q4 2023 in Review

PAX Financial Group sold out of Idexx Laboratories (IDXX) in Q4 2023, closing a stake of 1,255 shares — an estimated $549K sold.

PAX Financial Group first reported a position in IDXX in Q4 2021 and held it in 2 quarters. The position peaked at $549K in Q3 2023. 1,153 funds tracked by Wall St. Rank hold IDXX as of Q4 2023.

  • PAX Financial Group reported no remaining Idexx Laboratories position as of Q4 2023 after selling out during the quarter.
  • PAX Financial Group sold 1,255 Idexx Laboratories shares in Q4 2023, an estimated $549K.
  • PAX Financial Group first reported a position in Idexx Laboratories in Q4 2021 and held it in 2 quarters.
  • PAX Financial Group's Idexx Laboratories position peaked at $549K in Q3 2023.
  • 1,153 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2023.

Based on PAX Financial Group's 13F filing for Q4 2023, filed 12 Feb 2024.